Persistent damage to Enterocytozoon bieneusi, with persistent symptomatic relief, after combined furazolidone and albendazole in AIDS patients. - Wikidata - awgldk - TriplyDB

Persistent damage to Enterocytozoon bieneusi, with persistent symptomatic relief, after combined furazolidone and albendazole in AIDS patients.

Persistent damage to Enterocytozoon bieneusi, with persistent symptomatic relief, after combined furazolidone and albendazole in AIDS patients.

http://www.wikidata.org/entity/Q37227639

about

Therapeutic strategies for human microsporidia infections Management of infectious diarrhoea Management of protozoa-related diarrhea in HIV infection.

P2860

Q28256376-B21DED08-3375-437C-9C76-C53F571FB7F9 Q35598312-F1BA6677-3551-40B4-9F80-ED797A60430A Q35917249-AF5B3D69-0A97-4638-AD99-CE5BA73D28A3

P2860

Persistent damage to Enterocytozoon bieneusi, with persistent symptomatic relief, after combined furazolidone and albendazole in AIDS patients.

http://www.wikidata.org/entity/Q37227639

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 1998

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Persistent damage to Enterocyt ...... albendazole in AIDS patients.

@en

Persistent damage to Enterocyt ...... albendazole in AIDS patients.

@nl

type

label

Persistent damage to Enterocyt ...... albendazole in AIDS patients.

@en

Persistent damage to Enterocyt ...... albendazole in AIDS patients.

@nl

prefLabel

Persistent damage to Enterocyt ...... albendazole in AIDS patients.

@en

Persistent damage to Enterocyt ...... albendazole in AIDS patients.

@nl

P1433

Q37227639-AAB158C4-841D-4181-AF38-3011C4832369

P1476

Q37227639-B93AB81E-9FCE-4C56-8C75-3919E6600E50

P2093

Q37227639-037645C2-AA93-4DCE-91BD-9A56E5133F73

Q37227639-1A9CB808-F5E2-4F33-85A5-D876421F53F8

Q37227639-1DCAAB00-42F2-48B9-9F6D-D9F09A99685E

Q37227639-2CEEF9AC-3E81-493C-A516-D4F4BE34B75C

Q37227639-3167FD7F-E921-4FD5-8A47-508B83CF920B

Q37227639-A214C03C-8238-441C-9C53-4B39FA91C558

Q37227639-A8AD0C39-EE3D-4655-A59E-B48E76E7AB33

Q37227639-CA665B5D-D375-48E2-B9C6-2ECDCA2EE3F7

Q37227639-DAD1106A-C6FC-4E87-999C-6660D4E836D6

Q37227639-EF88B964-47EE-4989-A104-90E0EB8C3434

P2860

Q37227639-0A49D6B7-7D38-4F65-B510-A2B0515C88B9

Q37227639-1F1C4C35-F121-4743-8EAB-27CCFA8C4A65

Q37227639-2BF8D5B4-E4A4-4346-A5BD-1B1DE95EF512

Q37227639-3A8E5E06-5886-4B45-81E1-DDAB6A5D75E0

Q37227639-4E9B62B4-6A2B-496D-85E0-32CD8EE4A59E

Q37227639-4F625EF0-25A4-49C1-A250-E99F8DA7B975

Q37227639-5075344B-02CF-48C5-A07C-A4D121C4947E

Q37227639-5DB7677A-91C0-4105-B627-CDB8B9F6EF12

Q37227639-5EAA8CA7-6F19-4EE2-B762-503CB8C868C9

Q37227639-659F0902-3B93-44C8-8A8E-0661557C1DEF

P304

Q37227639-AFEE66EE-38CE-4EC0-917A-52F51B5CD510

P31

Q37227639-5C65E46A-C99B-48FA-8111-C7FAE9F37AE4

P356

Q37227639-E36C6572-F186-4B3A-9492-F5D6F5FCB830

P407

Q37227639-066AE26D-691E-4A80-944D-F0A40D19526F

P433

Q37227639-C53AF423-1773-4252-A75D-CB160C8F917E

P478

Q37227639-8ED1EF9A-6B02-47BD-A93E-572AE6CBD124

P577

Q37227639-5153F6F4-9D76-4C8B-A61A-974F69E1E086

P5875

Q37227639-4B3E029A-52CA-4434-9AB8-70ECAE13B66A

P698

Q37227639-9EFF51DF-367A-4262-8DB6-308BD4686198

P921

Q37227639-3B6ED14C-EAEE-443C-9697-BA31E5C7E230

P932

Q37227639-889B35D3-5420-4785-84E4-0D740A1D8751

P356

P1433

Journal of Clinical Pathology

P1476

Persistent damage to Enterocyt ...... albendazole in AIDS patients.

@en

P2093

Di Lollo S

http://www.w3.org/2001/XMLSchema#string

Dionisio D

http://www.w3.org/2001/XMLSchema#string

Leoncini F

http://www.w3.org/2001/XMLSchema#string

Manneschi LI

http://www.w3.org/2001/XMLSchema#string

Orsi A

http://www.w3.org/2001/XMLSchema#string

Papucci A

http://www.w3.org/2001/XMLSchema#string

Pozzi M

http://www.w3.org/2001/XMLSchema#string

Sterrantino G

http://www.w3.org/2001/XMLSchema#string

Tani A

http://www.w3.org/2001/XMLSchema#string

Vinattieri MA

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of albendazole, fumagillin, and TNP-470 on microsporidial replication in vitro

Intracellular development of Enterocytozoon, a unique microsporidian found in the intestine of AIDS patients.

Potential efficacy of fumagillin in intestinal microsporidiosis due to Enterocytozoon bieneusi in patients with HIV infection: results of a drug screening study. The French Microsporidiosis Study Group.

Thalidomide: a novel therapy for microsporidiosis.

Diagnosis of intestinal and disseminated microsporidial infections in patients with HIV by a new rapid fluorescence technique.

Absorption, distribution, metabolism, and excretion of furazolidone. A review of the literature.

Adverse reactions to furazolidone and other drugs. A comparative review.

Enterocytozoon bieneusi in AIDS: symptomatic relief and parasite changes after furazolidone.

Autopsy verification of Encephalitozoon intestinalis (microsporidiosis) eradication following albendazole therapy.

Electron microscopic changes in Enterocytozoon bieneusi following treatment with albendazole.

P304

731-736

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JCP.51.10.731

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

1998-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13266836

http://www.w3.org/2001/XMLSchema#string

P698

10023334

http://www.w3.org/2001/XMLSchema#string

P921

P932

500926

http://www.w3.org/2001/XMLSchema#string